Log In
Print this Print this

PD-L1 IHC 22C3 pharmDx

  Manage Alerts
Collapse Summary General Information
Company Agilent Technologies Inc.
DescriptionImmunohistochemical assay using monoclonal mouse anti-PD-L1, clone 22C3 to detect PD-L1 protein in formalin-fixed, paraffin-embedded (FFPE) non-small cell lung cancer (NSCLC) tissue
Molecular Target
Mechanism of ActionDiagnostic
Therapeutic ModalityDiagnostics
Latest Stage of DevelopmentMarketed
Standard IndicationCancer, Diagnostic
Indication DetailsDetect PD-L1 protein in NSCLC tissue
Regulatory Designation

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today